This inventor holds 9 USPTO granted patents. Top assignees: Newcastle University Ventures Limited, Cancer Research Campaign Technology Limited. Active years: 1998-2004.
Location History:
- Newcastle Upon Tyne, GB (2001)
- Northumberland, GB (1998 - 2004)
Company Filing History:
7 out of 14 
2 out of 62 Years Active: 1998-2004
Title: Innovations and Contributions of Roger J Griffin
Introduction
Roger J Griffin is a notable inventor based in Northumberland, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzymes involved in cell proliferation and DNA repair.
Latest Patents
Griffin holds a total of 9 patents. His latest patents include a range of pyrimidine derivatives that act as inhibitors of cyclin-dependent kinases (CDKs). These compounds provide potential therapeutic options for treating tumors and other disorders related to cell proliferation. Additionally, he has developed a series of 3-oxybenzamide and quinazolinone compounds that serve as potent inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP). These compounds are designed to enhance the effectiveness of cytotoxic drugs and radiotherapy.
Career Highlights
Throughout his career, Griffin has worked with various organizations, including Newcastle University Ventures Limited and Cancer Research Campaign Technology Limited. His work has focused on creating innovative solutions to complex medical challenges.
Collaborations
Griffin has collaborated with notable individuals such as Alan H Calvert and David Richard Newell. These partnerships have contributed to the advancement of his research and the development of his patented inventions.
Conclusion
Roger J Griffin's work exemplifies the impact of innovative thinking in the field of medicine. His contributions continue to pave the way for new therapeutic approaches in treating serious health conditions.